FFAR4 and obesity disorder: In humans, a non-synonymous mutation of FFAR4 associated with obesity whereas global knockout of FFAR4 in HFD mice led to weight gain, glucose intolerance, fatty liver, and insulin resistance, suggesting that intact FFAR4 signaling is critical for maintaining systemic glucose homeostasis (91).